GEN Exclusives

More »

GEN News Highlights

Back to Item »

Optivia Wins $1.85M Phase II Grant to Develop Drug-Drug Interaction Assays

Part of grant will fund UCSF work to profile 2,000 prescription drugs against key liver and kidney transporters.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Alzheimer's Therapies

Do you think an effective treatment for Alzheimer’s will be found within the next 10–15 years?